ED
AGNC icon

Exane Derivatives’s AGNC Investment AGNC Stock Holding History

Exane Derivatives’s Portfolio AGNC Stock Details AGNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-349
Closed -$5.85K – 1045
2021
Q1 		$5.85K Sell
349
-624
-64% -$10.1K ﹤0.01% 618
2020
Q4 		$15.2K Sell
973
-906
-48% -$13.4K ﹤0.01% 514
2020
Q3 		$26.1K Sell
1,879
-1,234
-40% -$17K 0.01% 414
2020
Q2 		$40.2K Sell
3,113
-4,139
-57% -$51.9K 0.01% 369
2020
Q1 		$76.7K Hold
7,252
– – 0.02% 313
2019
Q4 		$132K Sell
7,252
-2,087
-22% -$35.5K 0.02% 293
2019
Q3 		$150K Hold
9,339
– – 0.03% 277
2019
Q2 		$157K Sell
9,339
-418
-4% -$7.27K 0.03% 291
2019
Q1 		$176K Buy
9,757
+1,216
+14% +$21.7K 0.03% 232
2018
Q4 		$150K Hold
8,541
– – 0.03% 280
2018
Q3 		$158K Buy
8,541
+1,256
+17% +$23.9K 0.03% 268
2018
Q2 		$137K Sell
7,285
-1,087
-13% -$20.5K 0.02% 296
2018
Q1 		$157K Sell
8,372
-3,085
-27% -$58.5K 0.03% 252
2017
Q4 		$231K Sell
11,457
-1,555
-12% -$32K 0.04% 229
2017
Q3 		$282K Sell
13,012
-4,566
-26% -$97.6K 0.05% 179
2017
Q2 		$374K Buy
17,578
+3,391
+24% +$70.5K 0.08% 156
2017
Q1 		$282K Buy
14,187
+278
+2% +$5.36K 0.06% 170
2016
Q4 		$252K Buy
+13,909
New +$264K 0.05% 193
2016
Q3 		– Sell
-10,099
Closed -$200K – 627
2016
Q2 		$200K Sell
10,099
-826
-8% -$15.6K 0.03% 199
2016
Q1 		$204K Buy
10,925
+1,208
+12% +$21.5K 0.03% 193
2015
Q4 		$168K Sell
9,717
-798
-8% -$14.5K 0.02% 170
2015
Q3 		$197K Sell
10,515
-2,297
-18% -$44.1K 0.02% 187
2015
Q2 		$235K Sell
12,812
-455
-3% -$9.37K 0.03% 198
2015
Q1 		$283K Buy
13,267
+1,975
+17% +$42.7K 0.03% 180
2014
Q4 		$246K Buy
+11,292
New +$255K 0.03% 193

Other funds holding AGNC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Exane Derivatives's AGNC Position: Q2 2021 in Review

Exane Derivatives sold out of AGNC Investment (AGNC) in Q2 2021, closing a stake of 349 shares — an estimated $5.85K sold.

Exane Derivatives first reported a position in AGNC in Q4 2014 and held it in 25 quarters. The position peaked at $374K in Q2 2017. 471 funds tracked by Wall St. Rank hold AGNC as of Q2 2021.

  • Exane Derivatives reported no remaining AGNC Investment position as of Q2 2021 after selling out during the quarter.
  • Exane Derivatives sold 349 AGNC Investment shares in Q2 2021, an estimated $5.85K.
  • Exane Derivatives first reported a position in AGNC Investment in Q4 2014 and held it in 25 quarters.
  • Exane Derivatives's AGNC Investment position peaked at $374K in Q2 2017.
  • 471 funds tracked by Wall St. Rank held AGNC Investment as of Q2 2021.

Based on Exane Derivatives's 13F filing for Q2 2021, filed 28 Jul 2021.